Development of Group A streptococcal vaccines: an unmet global health need

Post-infectious group A streptococcal autoimmune syndromes and the heart

(2015) William John Martin et al.   AUTOIMMUNITY REVIEWS

Streptococcus pyogenes strains in Sao Paulo, Brazil: molecular characterization as a basis for StreptInCor coverage capacity analysis

(2015) Samar Freschi de Barros et al.   BMC INFECTIOUS DISEASES

Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography: A Scientific Statement From the American Heart Association

(2015) M. H. Gewitz et al.   CIRCULATION

Controlling acute rheumatic fever and rheumatic heart disease in developing countries

(2015) Jessica L. de Dassel et al.   CURRENT OPINION IN PEDIATRICS

Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci

(2015) Michael F Good et al.   Expert Review of Vaccines

A Synthetic M Protein Peptide Synergizes with a CXC Chemokine Protease To Induce Vaccine-Mediated Protection against Virulent Streptococcal Pyoderma and Bacteremia

(2015) Manisha Pandey et al.   JOURNAL OF IMMUNOLOGY

Streptococcal Pharyngitis in Schoolchildren in Bamako, Mali

(2015) Milagritos D. Tapia et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma

(2015) Asha C. Bowen et al.   PLoS One

Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus

(2015) Shu Ki Tsoi et al.   Journal of Immunology Research

The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus,scabies, and nasal carriage

(2014) Asha C Bowen et al.   BMC INFECTIOUS DISEASES

Added Value of the emm-Cluster Typing System to Analyze Group A Streptococcus Epidemiology in High-Income Settings

(2014) S. T. Shulman et al.   CLINICAL INFECTIOUS DISEASES

The emm-Cluster Typing System for Group A Streptococcus Identifies Epidemiologic Similarities Across the Pacific Region

(2014) Noémie Baroux et al.   CLINICAL INFECTIOUS DISEASES

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

(2014) M. J. Walker et al.   CLINICAL MICROBIOLOGY REVIEWS

Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)

(2014) Liesl Zühlke et al.   EUROPEAN HEART JOURNAL

Rheumatic Fever, Autoimmunity, and Molecular Mimicry: The Streptococcal Connection

(2014) Madeleine W. Cunningham   INTERNATIONAL REVIEWS OF IMMUNOLOGY

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

(2014) Martina Sanderson-Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance

(2014) Mark R Davies et al.   NATURE GENETICS

Rheumatic fever revisited

(2014) Madeleine W. Cunningham   Nature Reviews Cardiology

Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop

(2014) Nicole J. Moreland et al.   VACCINE

Primary Prevention of Acute Rheumatic Fever and Rheumatic Heart Disease With Penicillin in South African Children With Pharyngitis

(2013) James Irlam et al.  

Long-Term Antibody Memory Induced by Synthetic Peptide Vaccination Is Protective against Streptococcus pyogenes Infection and Is Independent of Memory T Cell Help

(2013) M. Pandey et al.   JOURNAL OF IMMUNOLOGY

Revisiting the pathogenesis of rheumatic fever and carditis

(2013) Rajendra Tandon et al.   Nature Reviews Cardiology

Progress Toward a Global Group A Streptococcal Vaccine

(2013) Andrew C. Steer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Group A Streptococcal emm Type Prevalence Among Symptomatic Children in Cape Town and Potential Vaccine Coverage

(2013) Mark E. Engel et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Inactivation of the CovR/S Virulence Regulator Impairs Infection in an Improved Murine Model of Streptococcus pyogenes Naso-Pharyngeal Infection

(2013) Faraz M. Alam et al.   PLoS One

StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice

(2013) Edilberto Postol et al.   PLoS One

Potential coverage of a multivalent M protein-based group A streptococcal vaccine

(2013) James B. Dale et al.   VACCINE

Group A streptococcal vaccines: Paving a path for accelerated development

(2013) James B. Dale et al.   VACCINE

Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes

(2013) Karine M. De Amicis et al.   VACCINE

Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

(2013) Ivette Caro-Aguilar et al.   Human Vaccines & Immunotherapeutics

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

(2012) D.J. McMillan et al.   CLINICAL MICROBIOLOGY AND INFECTION

Streptococcal skin infection and rheumatic heart disease

(2012) Tom Parks et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Invasive Group A Streptococcal Disease

(2012) Andrew C. Steer et al.   DRUGS

Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone

(2012) Peter G. Maamary et al.   FASEB JOURNAL

Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand

(2012) Richard J Milne et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Incidence of acute rheumatic fever in New Zealand children and youth

(2012) Richard J Milne et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life

(2012) Wendy E. Hoy et al.   KIDNEY INTERNATIONAL

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case

(2012) Giuliano Bensi et al.   MOLECULAR & CELLULAR PROTEOMICS

Screening for rheumatic heart disease: current approaches and controversies

(2012) Kathryn Roberts et al.   Nature Reviews Cardiology

Streptococcus pyogenes SpyCEP Influences Host-Pathogen Interactions during Infection in a Murine Air Pouch Model

(2012) Nico Chiappini et al.   PLoS One

Acute Post-Streptococcal Glomerulonephritis in the Northern Territory of Australia: A Review of 16 Years Data and Comparison with the Literature

(2011) Catherine S. Marshall et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate

(2011) Milton T. Guerino et al.   VACCINE

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

Anti-Group A Streptococcal Vaccine Epitope

(2010) Luiza Guilherme et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Parameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci

(2010) Peter G. Maamary et al.   Journal of Innate Immunity

The burden of kidney disease in Indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease

(2010) Andrew White et al.   JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation

(2010) Julie M. Skinner et al.   MICROBIAL PATHOGENESIS

Correlation between Bioluminescence and Bacterial Burden in Passively Protected Mice Challenged with a Recombinant Bioluminescent M49 Group A Streptococcus Strain

(2009) M. Sheel et al.   Clinical and Vaccine Immunology

Seven‐Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates

(2009) Stanford T. Shulman et al.   CLINICAL INFECTIOUS DISEASES

Group A streptococcal vaccines: facts versus fantasy

(2009) Andrew C Steer et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

(2009) Andrew C Steer et al.   LANCET INFECTIOUS DISEASES

Prospective Surveillance of Streptococcal Sore Throat in a Tropical Country

(2009) Andrew C. Steer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

School-Based Prevention of Acute Rheumatic Fever

(2009) Diana Lennon et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Prevention of Rheumatic Fever

(2009) Jonathan Carapetis et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Burden and Economic Cost of Group A Streptococcal Pharyngitis

(2008) E. Pfoh et al.   PEDIATRICS